The Benchmark Company as co-manager for MTBC’s Upsizing and Pricing of $24.0 Million Public Offering of Preferred Stock
The Benchmark Company acted as financial advisor to Rainmaker Worldwide in Sphere 3D’s acquisition.
The Benchmark Company’s Senior Equity Analyst, Aydin Huseynov, M.D., CFA. on COVID-19 backup plan.
The Benchmark Company Announces “Healthcare House Call” Upcoming Virtual 1×1 Investor Conference
The Benchmark Company Announces Closing of $8 Million Registered Direct Offering for Cinedigm Corp.
The Benchmark Company acted as a Co-Manager of MTBC’s Largest Public Offering of Non-Convertible Preferred Stock with $20.7 Million in Gross Proceeds.
The Benchmark Company Announces Closing of Public Offering of $5.0 Million for Hoth Therapeutics, Inc.
The Benchmark Company Expands Its Biotechnology Focus With The Addition Of Dr. Aydin Huseynov And Dr. Okechukwu Linton
The Benchmark Company Announces Closing of Public Offering of $4.5m for Seelos Therapeutics, Inc.
Benchmark Managing Director and Internet & Media Analyst Daniel Kurnos, CFA, Preview’s Amazon’s Amazing 4Q Results
